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Summary
In HCM, LGE defined LV fibrosis is commonplace and
generally not considered in the RV. However, by CMR-
LGE it may be more commonplace than expected.
Background
CMR has become the leading technique to detect hyper-
trophic cardiomyopathy (HCM) providing complete cov-
erage of both ventricles with high spatial resolution.
Late gadolinium enhancement (LGE) accurately identi-
fies regions of myocardial fibrosis. Via CMR, innumer-
able studies have established LVH as the predominant
phenotypic expression. It is well known that myocardial
fibrosis can occur in patients with HCM and is indepen-
dently linked to worse prognosis than those without
fibrosis by CMR. The genotypic expressions would
appear to affect the entire heart yet, conventionally;
descriptions have been limited to the LV, likely due to
the inability to image the smaller, thinner RV. Thus, lit-
tle information is available about the RV in HCM. We
h y p o t h e s i z et h e r em a yb eR Vi n v o l v e m e n ti nH C M
when incorporating CMR analysis for RV hypertrophy
and fibrosis.
Methods
Review of all patients referred for HCM was performed.
SSFP/LGE was used to diagnose patients with HCM,
using gadolinium administration (MultiHance,
0.15mmol/kg, Bracco Diagnostics, Princeton, NJ). Post-
injection LGE images were obtained via T1-weighted, IR
preps. Regions of myocardium with abnormally high sig-
nals (>2SD) were designated as fibrotic. LV/RVMass
Index was calculated.
Results
Via 99 patients referred for HCM from 2006-2011, 28
(28%) were confirmed to be HCM via CMR. Image
quality was judged excellent in 27/28 (97%). The mean
LVMI was 97±40gm2 (> 2SDabove normal) while the
mean RVMI was 22±5 gm2 (>1SD > normal). All
patients met formal LVH criteria while 17/28 (61%) met
RVH criteria. LV fibrosis was evident in 24/28 (86%)
while most, 19/28 (67%), also had evidence for RV fibro-
sis. No patients with RV fibrosis had absent LV fibrosis.
In neither the LV nor RV did the degree of hypertrophy
predict the likelihood for fibrosis (98±38 vs.84±26g/m2
and 22±24 vs.21±25g/m2, respectively).
Conclusions
The high frequency of RV fibrosis in the setting of
HCM is unforeseen presumably as this phenomenon is
not anticipated. However, given the genetic abnormal-
ities, there is no reason to expect the phenotypic expres-
sion should be limited to just the LV. Interestingly,
similar for LVH, the degree of RVH had little predictive
power to define fibrosis.
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